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Abstract Brain-Computer Interface (BCI) research
and (future) applications raise important ethical issues
that need to be addressed to promote societal acceptance
and adequate policies. Here we report on a survey we
conducted among 145 BCI researchers at the 4th
International BCI conference, which took place in
May–June 2010 in Asilomar, California. We assessed
respondents’ opinions about a number of topics. First,
we investigated preferences for terminology and defi-
nitions relating to BCIs. Second, we assessed respond-
ents’ expectations on the marketability of different BCI
applications (BCIs for healthy people, BCIs for
assistive technology, BCIs-controlled neuroprostheses
and BCIs as therapy tools). Third, we investigated
opinions about ethical issues related to BCI research for
the development of assistive technology: informed
consent process with locked-in patients, risk-benefit
analyses, team responsibility, consequences of BCI on
patients’ and families’ lives, liability and personal
identity and interaction with the media. Finally, we
asked respondents which issues are urgent in BCI
research.
Keywords Brain-computer interfaces . Brain-machine
interfaces . Neuroethics . Neuroimaging . Locked-in
syndrome
Introduction
The research field of Brain-Computer Interface (BCI)
is growing rapidly. The scientific foundations of BCI
research were established decades ago, mostly by
medical doctors, neurophysiologists, psychologist and
physicists (e.g. [6, 7, 14, 15, 18–20, 33, 34, 67, 70].
Recent contributions from other fields such as human-
computer interaction (HCI), electrical engineering, com-
puter science and artificial intelligence have fostered
tremendous innovation in BCI research. This has resulted
in a new (additional) focus on non-medical applications
(e.g. gaming, military use, and workplace devices). The
increasing number of contributors, applications, and
users has exposed some controversial topics and poten-
tial roadblocks. In particular, researchers and policy
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makers are becoming more and more aware of emerging
ethical issues related to BCI research, development and
dissemination. BCIs are also increasingly prominent in
popular culture and thus, perceived by the general public.
For example, popular TV shows such as House, Star
Trek, and Fringe have aired episodes that present BCIs
[3]. Media frequently and inaccurately report that
science is now capable of reading peoples’ thoughts
and dreams, even when people are in a vegetative state
(e.g.: [1, 11, 21, 46, 65]). However, most BCI
researchers described in these articles merely try to
obtain a binary signal, a so-called single switch, from a
patient to enable control of an assistive technology (AT)
device. As long as patients have a single switch, either a
residual muscle movement or a BCI-controlled signal,
they can use AT [29].
In 2006, Wilhelm and colleagues reported on their
attempt to communicate with a complete locked-in
patient. Through food imagery, the patient manipulated
her salivary pH and could give yes/no answers to
questions [68]. In an accompanying editorial, Phillips
responded to this article with the critical question ‘even
when you can communicate with a locked-in patient,
should you do it?’1 [48]. Phillips argued that the
development of Brain-Computer Interfaces for commu-
nication might compel physicians and patients to
consider life-sustaining treatments more often, and that
patients are therefore at higher risk of becoming locked-
in. However, the assumption that quality of life in the
locked-in state is necessarily low, as suggested by
Phillips, is factually wrong [28, 29, 32, 52, 58]. Phillips
further argued that life-sustaining treatments might
inflict heavy burdens on the quality of life of the
patients and the emotional and financial state of
the caregivers. Dobkin also suggests that the use/
availability of BCIs as assistive technology might
bring financial, physical and emotional burden to
persons [13]. Both authors urge BCI researchers to
address ethical concerns related to Brain-Computer
Interfacing.
Phillips and Dobkin raise important issues that the
BCI community should address further. BCI research
and future applications do not necessarily have only
beneficial consequences, but may also lead to harmful
consequences.
The nascent neuroethical debate has identified
several topics of importance to Brain-Computer
Interfacing: 1) obtaining informed consent from
people who have difficulty communicating, 2) risk/
benefit analysis 3) shared responsibility of BCI teams
(e.g. how to ensure that responsible group decisions
can be made), 4) the consequences of BCI technology
for the quality of life of patients and their families, 5)
side-effects (e.g. neurofeedback of sensorimotor rhythm
training is reported to affect sleep quality) 6) personal
responsibility and its possible constraints (e.g. who is
responsible for erroneous actions with a neuropros-
thesis?), 7) issues concerning personality and person-
hood and its possible alteration, 8) therapeutic
applications, including risks of excessive use, 9)
questions of research ethics that arise when progressing
from animal experimentation to application in human
subjects, 10) mind-reading and privacy, 11) mind-
control, 12) selective enhancement and social stratifica-
tion, 13) human dignity, 14) mental integrity, 15) bodily
integrity, 16) regulating safety, 17) communication to the
media [4, 8, 9, 17, 22, 40, 53, 54, 61, 63].
The Emerging Neuroethical Debate
However, the results from this initial debate do not
seem to be fully integrated into BCI research. BCI
researchers, like neuroscientists, may have good
reason for their reluctance to wade into ethics. The
questions raised are likely to be open-ended, and their
arrival in the world both inside and outside the
laboratory may be some way off [16]. Furthermore,
many BCI researchers come from an engineering
background, and may have less training and interest
in ethical matters. Finally, BCI researchers may be
interested in ethical issues they are confronted with in
daily work situations, while some ethicists focus on
more abstract, but no less relevant, themes like
enacted mind or embodied mind [17, 66]. Addition-
ally, the public community may be more concerned
with issues like mind-reading, animal experimentation
and military applications. These different viewpoints
and interests notwithstanding, we believe it is worth-
while to invite and support the BCI community to
articulate its (varying) views as clearly as possible.
Obviously, this is not something that can be accom-
plished in one big swoop, as extracting and clearly
1 Nijboer and Broermann, the latter author being a locked-in
patient, responded to Philips’ question with another question:
“When you can communicate with a locked-in patient, why
should you not do it?” [42].
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identifying the opinions of the members of a young,
multi-disciplinary research field will take time for
thinking about, discussing thoroughly and articulating
clearly the ethical issues perceived to be central and/
or most pressing. We therefore submit our work as
one of the first incomplete steps in a long-range
attempt towards clarifying the views of at least a
segment of the BCI research community. Work such
as provided here may invite other BCI-researchers to
give their thoughts on the ethical issues involved.
During the 4th International BCIMeeting, which took
place at the Asilomar conference centre in California, we
conducted a survey among the attendees to help assess
the views andmoral concerns of the BCI community, and
lay the foundations for developing BCI research efforts
into a more mature effort. After extensive internal
discussion and pilot testing, our team developed a two-
part survey shown in Appendix I. One portion of the
survey focused on the ethical issues that are important
for the maturing technology of BCI. The second part of
the survey addressed issues such as terminology, criteria
for BCI definition, matters of urgency and expected
marketability. The 4th International BCI meeting was
the largest BCI meeting ever (289 estimated attendees)
and provided an exceptional opportunity to explore key
issues amongst colleagues, although it has to be noted
that many other qualified respondents (e.g. from the
field of human-computer interaction or ambient intelli-
gence) do not typically attend this meeting which may
have biased our findings (see ‘Some thoughts on the
survey’ in the Discussion). The conference is focused
on systems that measure brain signals, extract relevant
features from those brain signals and translate them into
commands to software or hardware applications. This
close community refers to itself as the BCI community,
although many other persons use the phrase brain-
computer interface also to refer to Deep Brain Stimu-
lation, vagal nerve stimulation or cochlear implants.
Thus, it needs to be noted that at this BCI conference
only brain-to-computer systems are the center of focus.
What’s in a Name?
Individual assessments of the ethical implications of
research and applications in a multi-disciplinary and
multi-faceted area as BCI will depend largely on the
individual’s interpretation on what a BCI is and isn’t.
For example, someone who excludes certain research
directions or applications as not being part of BCI
may be less interested in certain ethical issues than a
person with a broader definition. Moreover, the ethical
debate will be facilitated with common terminology
concerning BCIs, which has proven highly problematic.
The first reason for the variance in terminology is that
BCIs may have several functions. The term BCI, for
example, may be used for a gaming application for
healthy users, but also as an assistive technology for a
person in the locked-in state. Depending on functions
and target users, different ethical issues will arise. A
second complication is that some BCIs use invasive
recordings from the brain, whereas others use non-
invasive recordings. The pervasiveness of the imaging
technique used for BCIs may greatly influence the
ethical debate, such as when a risk/benefit analysis is
made. A third issue consists of whether people consider
BCIs an outward-directional (from the brain to the
computer/machine) or an inward-directional (from the
computer/machine to the brain) interface. Are BCIs
systems that measure brain signals and “translate” this
input into output signals? Or can a BCI also be a system
that uses externally generated input, e.g. Deep Brain
Stimulation (DBS), to modify brain activity?
Some articles that discuss ethical issues and BCIs rely
on a very broad definition of ΒCIs. For example, Racine
and colleagues investigated media coverage of neuro-
stimulation technologies and other contemporary neuro-
science topics and included the terms “brain-machine
interface”, “brain-computer interface” and “neural pros-
thesis” in the search for printed media about these topics
[50, 51]. They clearly perceive invasive BCI as
examples of neurostimulation techniques (personal
communication). Similarly, Demetriades and colleagues
recently argued that Brain-Machine Interfaces (BMIs)
should solely be used for purposes of medical
treatment, and all other applications should be imme-
diately banned as unethical. However, they came to this
conclusion because they included the implantation of
deep brain stimulation electrodes in the definition of
BMIs and focused heavily on risks of mind control that
are unrealistic with conventionally defined BCIs [12].
Schermer, who discusses the conceptual and moral
implications of Brain-Machine Interaction, also
includes cochlear implants, deep brain stimulation in
her definition of Brain-Machine Interfaces [54].
Furthermore, she describes, as an example of neuro-
feedback, a new method for preventing epilepsy
attacks with the aid of Vagal Nerve Stimulation
(VNS). Changes in brainwaves can be detected and
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used to predict an oncoming epileptic attack. This
warning system can then generate an automatic
reaction from the VNS system which stimulates the
vagal nerve and prevents the attack [54]. This
example of neurofeedback need not be considered a
typical example by the so-called BCI community.
Apart from terminology, there are other topics that
may influence a person’s stance on ethical questions. For
example, people contributing to the debate may have
different opinions on what is currently feasible with BCIs
and which commercial BCIs are currently available.
Also, they may have different expectations about BCI
marketability in the future. Overly optimistic or pessi-
mistic predictions regarding functionality, benefit and
marketability of BCI products may have several con-
sequences. First, expectations of marketability of future
BCI products influence the timing and the pace of the
ethical debate. Secondly, beliefs about functionality and
benefit of BCI products influence the risk/benefit
analysis. For example, a locked-in patient may be told
during the informed consent procedure that the BCI is
“going to bring back his communication skills”, whereas
realistically the chances are much lower.
Below, we survey ethical opinions of BCI researchers,
preferences for terminology and definitions of BCI, and
expectations about marketability of BCIs.
Methods
Pilot Study
A pilot internet survey with 29 items was created to
elicit opinions on ethical aspects of BCI research,
terminology and matters of urgency. Items consisted of
multiple choice questions, open questions and rating
scales. The survey was distributed to members of the
group of BCI scientists at the Braingain Group of the
Radboud University of Nijmegen. Respondents were
asked to complete the survey and give feedback on the
relevance, quality and quantity of the questions.
The survey assessed 1) demographic informa-
tion, 2) opinions about terminology and definition
of BCIs, 3) opinions about BCI applications for
healthy users, 4) for assistive technology, 5) for
prosthesis, 6) for therapy tools. The largest part of
the survey was about 7) ethical aspects related to
BCI research and finally, assessed 8) opinions
about urgent issues in BCI research.
Nine BCI researchers (1 female, 8 males), with
different degrees of expertise, entered the pilot study.
Respondents needed between 15 and 30 min to
complete the survey, which was evaluated as too time
consuming. Therefore, we revised the survey such that
the time needed to complete the survey was reduced to
an estimated maximum of 15 min. Respondents gave
constructive criticisms to the questions, so that we
revised items to be more concise. From the data we
could see variance in the answers, which supported the
notion that the survey could uncover the various
differences in opinions. Open questions about what is
needed to market BCIs in future did not result in many
answers and were thus omitted in the final survey.
Finally, more focus on the ethical part was ensured by
eliminating many general questions about BCIs.
The Asilomar Survey
The final Asilomar survey consisted of 24 items (see
Appendix I). The survey assessed 1) demographic
information and opinions about 2) preferred terminol-
ogy and definition of BCI, 3) marketability of different
types of BCI applications, 4) ethical aspects related to
BCI research, development and dissemination and 5)
matters of urgency. One final open question asked
respondents which questions should have been included
in the survey that were not included. The survey was
available through internet and on paper.
At the 4th International BCI conference at the
Asilomar conference grounds, we encouraged partic-
ipation in the survey through posters, two oral
announcements at general lectures and one email.
One week after the conference a follow-up email was
send to all attendees of the conference to encourage
final participation. The survey was closed 2 weeks
after the conference. Throughout the paper the word
“respondents” will refer to the BCI researchers who
participated in the survey, while “participants” will
refer to persons participating in BCI studies.
Results
Respondents’ Profiles
A total of 289 persons are estimated to have attended
the 4th International BCI conference. People were not
asked not to share the survey internet link with other
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BCI scientists they might know, so there may have
been more persons that learned about the existence of
the survey. For convenience, we assume that 289
persons were asked to participate in the survey. One
hundred and 66 persons responded to the request for
participation (57.4%). One hundred and 45 persons
(50.2%) completed the whole survey, although some
items were left unanswered with the comment that
respondents did not want to answer that question.
Consequently, we will indicate how many respondents
answered each item in the Results section. Respondents’
details can be found in Table 1. One respondent
preferred not to indicate his/her demographical data.
Respondents consisted of 105 males and 39 females.
Seventy three persons were aged between 18 and 30, 69
persons between 31 and 55, and two persons were aged
between 56 and 70. The sample consisted of persons
from various disciplines (see Fig. 1): neuro-, computer
or cognitive scientists, electrical engineers, psycholo-
gists etc. The year in which respondents began with
BCI research ranged from 1970 to 2010. Only 12
respondents started with BCI research before 2000.
However, this is difficult to avoid due to the youth of
the BCI research field, with the substantial majority of
publications in the last few years [5, 53]. We will refer
to this group as “experienced researchers”. Thirty-nine
respondents, whom we will refer to as “moderately
experienced researchers”, started with BCI research
between 2000 and 2005. Another 92 persons, “new
researchers” started between 2006 and 2010. About one
third of the respondents were PhD students.
Eleven respondents worked as BCI researchers in
Asia, 60 respondents in Europe and 73 respondents in
North-America.
Terminology and Definition of BCIs
First, the survey assessed which name the respondents
preferred for systems that “measure signals from the
central nervous system and “translate” those signals
into output signals”. Notably, this phrasing refers only
to devices that read from the CNS. Thus, we
specifically asked respondents for an appropriate
name for the systems we research and consider BCIs.
Table 2 provides an overview of the responses. The
majority of the respondents (83.6%) preferred the
phrase Brain-Computer Interface over Brain-Machine
Interface, although some commented that “both terms
are equally fine”. Others commented that they would
use BCI to refer to non-invasive systems and BMI to
refer to invasive systems. Researchers from Asia and
(moderately) experienced researchers seem to prefer
the term BMI more often than the new researchers.
Furthermore, we assessed respondents’ views on a
current “hot” topic in the BCI community. BCIs can
be distinguished based on the amount of “will” the
user exerted to produce the signal in the EEG [69,
72]. BCIs which rely on the user to self-regulate
certain brain patterns (e.g. mu rhythm or slow cortical
potentials) are dubbed as spontaneous or active BCI.
BCIs which rely on a evoked responses in a user’s
brain (e.g. P300 evoked potential) by presenting it
external stimuli but asking a user to willfully attend to
one of the stimuli are dubbed evoked or reactive
BCIs. Finally, BCIs which rely on ongoing brain
activity (e.g. arousal level) while the user is not
willfully producing these signals or attending any
special stimuli are dubbed passive BCIs.2 The BCI
community has debated whether passive BCIs should
be considered as BCIs as they do not seem to fit
Wolpaw’s definition from 2002 [69, 71]. In our
sample (N=143) all respondents agreed that active
systems are BCIs. Almost all respondents (95.1%)
2 Passive BCI may be applied to enhance human-computer
interaction. For example, when a user with disabilities is
working with assistive technology, but the passive BCI detects
sleep spindles in the brain pattern of the user, the system could
switch to standby mode or dim the lights.
Table 1 Overview of profiles of respondents
Demographics Number
of answers
Respondents
What’s your gender? N=144 Male 72.9%
Female 27.1%
What’s your age
(years)?
N=144 <18 0%
18–30 50.7%
31–55 47.9%
56–70 1.4%
>70 0%
In which year did
you start with
BCI research?
N=143 before 2000 8.4%
2000–2005 27.3%
2006–2010 64.3%
Where do you live
and perform this
occupation?
N=144 Asia 7.6%
Europe 41.7%
North-America 50.7%
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also consider reactive systems to be exemplary BCIs.
Although respondents are less sure about passive
systems, a majority (65.7%) also view these as BCIs.
Notably, passive systems seem more accepted as BCIs
in Asia (81.8%) and not well accepted as BCIs by
experienced researchers (41.7%).
Second, we asked respondents to evaluate several
examples and indicate whether they did or did not
consider the system a BCI. They could also indicate
that they did not know. Some systems can be
categorized as active, reactive and passive systems,
but we did not mention these phrases. Figure 2
provides an overview of the answers. Respondents
almost unanimously agreed that cursor control or
orthosis control based on self-regulation of slow
cortical potentials in the EEG or mu rhythm can be
considered as BCI examples. Sixty-four percent
considered fatigue monitor for drivers in a car that
was based on brain signals a BCI, but a similar
offline3 system to assess alertness in workers was not
considered to be a BCI by another 64% or the
respondents. Similar to the fatigue monitor, the
adaptation to the emotion of a user in a virtual
game was considered a BCI by 65% of the
respondents. Since a fatigue monitor and a emo-
tion adapter are examples of passive BCIs, the
results are compatible with the findings described
in the previous paragraph.
Opinions were divided about a number of issues.
Fifty-three percent of the respondents did not consider
an EEG lie detector as a BCI, but 41% did. Forty-four
percent of the respondents considered image detection
(in other words whether a recently presented object
stands out) as a BCI, although 37% did not. Nineteen
percent of the respondents indicated that they did not
know if they considered image detection as a BCI,
which may reflect that the example was not suffi-
ciently clear. We suspect that respondents felt they
could decide whether this was a BCI or not because
we did not specify whether image classification
would take in realtime or near realtime. This factor
has been indicated as particularly important for the
definition of a BCI (see next paragraph). Respondents
also did not agree whether a remote controlled rat was
an example of a BCI. Forty-four percent thought so,
and 38% did not think it is a BCI. Neuromarketing,
which uses the classification of brain responses to
advertisements or new products, also divides opinions.
Finally, 61% of the respondents would not consider a
retinal implant as a BCI example. These results
3 Offline BCI systems measure brain activity, but relevant
features are, unlike with online BCIs, not extracted and
“translated” to commands in real time. Rather, relevant features
in the signals are only extracted and classified after the
experiment.
Fig. 1 Overview of the pro-
fessional and occupational
activities of respondents.
They were allowed to
give several answers
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demonstrate that BCI researchers often do not agree on
what is and what is not a BCI.
Thirdly, we asked the respondents which of 6
elements (see Appendix I, item 11) is required for a
definition of a BCI, but respondents could also add
more elements in the comments. Half or more than
half of the respondents identified 4 elements as
crucial (in order of importance); a BCI:
1) must detect brain activity directly (without using
signals from peripheral nerves or muscles)
(83.8% of the respondents).
2) provides feedback in realtime, or neartime
(71.1% of the respondents).
3) must classify brain activity (60.6% of the
respondents).
4) provides feedback to the user that reflects
whether s/he successfully attained a goal (50.0%
of the respondents).
Only 20% of the respondents believed that it is
required that the user chooses to send a signal each
time. In other words, the device can also rely on
signals that the user produces involuntarily as with
Table 2 Overview of preferred name: BCI = Brain-Computer Interface; BMI = Brain-Machine Interface; BNCI = Brain/neuronal
Computer Interface and assessment of three different types of BCI. See Appendix I for the complete question
Terminology and Definition All Europe North-America Asia Experienced
experts
Moderately
experienced
experts
New
experts
Which name has your
preference?
BCI 83.6 87.7 78.9 90.9 66.7 81.6 86.4
BMI 12.9 10.5 15.5 9.1 25.0 18.4 9.1
Direct Neural Interface 3.6 1.8 5.6 0 8.3 0 4.5
BNCI 0 0 0 0 0 0 0
Number of answers 140 57 71 11 12 39 88
In your opinion, which of
these devices is a BCI?
(you may choose more
than one)
Evoked/reactive 95.1 98.3 95.8 81.8 91.7 97.4 95.6
Spontaneous/active 100 100 100 100 100 100 100
Emotive/passive 65.7 60.0 67.6 81.8 41.7 76.9 64.4
Number of answers 143 60 71 11 12 39 90
Fig. 2 The percentage of
people who did (orange)
or did not (blue) consider
the listed example as a BCI
or who did not know
(purple bar)
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passive BCIs. Similarly, only 9% of the respondents
believe a BCI is only a BCI when it is used solely for
the purpose of sending a message or command.
Comments from respondents reflected mainly the
question if ‘feedback’ is important. For example, one
respondent defines BCI as a “realtime or neartime
communication channel directly from the central
nervous system to a computer [and that] this
communication may be ‘active’ or ‘passive’, but need
not provide feedback to the user”. Another respondent
was of a different opinion: “If a BCI does not
provide feedback there is no ‘interface’ and the
device or system is simply a monitor. One could also
argue that user can receive feedback because they
sense human-computer interaction alters in concor-
dance with their state” Finally, only 1 respondent
remarked that “the communication can go in the
direction from the computer into the brain such as
with electrical stimulation to alter the state of the
brain”. If we would draw the conclusion from this
that a general trend is to emphasize feedback as an
essential aspect of BCI, then this is somewhat
inconsistent with the results from Fig. 2 that show
what applications are and are not considered to be an
example of BCI. As many as 43.8% of the
respondents consider a remote controlled rat as an
example of BCI, yet retinal implants are not
considered a BCI. Also, 24.8% of the respondents
consider Deep Brain Stimulation a Brain-Computer
Interface.
Thus, it is clear that “BCI” researchers differ
significantly amongst themselves about the defini-
tion of Brain-Computer Interfaces. More clarity
concerning the interpretation of what a BCI is (or
is not) is important, especially in discussions with
philosophers, policy makers, health care organiza-
tions, ethicists and the general public. However, we
do not want to attempt to provide a standard
definition here. Any such definition should ideally
be developed through consensus amongst many
established researchers, but it is more likely the
definition will evolve naturally over time.
At least, we would like to stress the current
variety in definitions, and the ensuing risk of
misinterpretation. Groups who address ethical or
other issues in BCI research should clarify their
interpretations of the term “BCI” and how this
might influence the specific nuances of their
(ethical) position.
Expected Marketability of BCIs
As discussed in the introduction, the expected
marketability of future BCI products influences the
timing and the pace of the ethical debate. However, a
myriad of future BCIs can be imagined. In the survey,
for convenience, we have ordered some BCI types
based on their function:
1. BCIs for healthy users
2. BCIs as assistive technology, which provides
compensation for loss of motor function (e.g.
BCI-controlled communication program or
wheelchair)
3. BCI-controlled prostheses, which restore motor
function by replacing a paralyzed limb by a
prosthesis (e.g. a BCI-controlled robotic arm
or leg)
4. BCIs as therapy tools, which help people with
psychological/neurological disorders to directly
use feedback of their brain activity for training/
recovery purposes (e.g. neurofeedback of senso-
rimotor rhythms may promote brain recovery
after stroke, neurofeedback of slow cortical
potentials may help improve attention).
Although a state-of-the-art technology assessment
would have to specify applications in more detail (for
example the invasiveness of the BCI), these questions
at least add some sense of the opinions of BCI
researchers on marketability. For each of these types
of BCIs, we asked respondents to indicate when they
expected such a BCI to become available on the
market. Options were 1) never, 2) between 0 and
5 years, 3) between 6 and 10 years, 4) more than
10 years, and 5) it already exists on the market. If
respondents believed such a BCI was already on the
market, then they were asked to comment which
group or company offers it. Figure 3 provides an
overview of the respondents’ answers.
First, 44.8% of the respondents (N=145) expect
BCIs for healthy people to become available on the
market within the next 5 years, 13.8% between 6
and 10 years and 12.4% in more than 10 years.
Few people (1.4%) believe it will never become
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available on the market and 27.6% of the
respondents believe it is already on the market.
The companies mentioned are Neurosky, Emotiv,
InterAxon, Mattel, Brain Actuated Technologies,
ZEO, OCZ, Uncle Milton, NIA, Ambien Audeo,
and Hitachi. Some respondents add a critical note,
for example: “if it [the products these companies are
selling] is really BCI and not EMG+EEG”. Another
respondent however specifies: “….what NeuroSky,
Emotiv, etc. are doing is BCI. But it’s crude and not
what we all dreamed of seeing (the “EEG-headset-
controls-computer-in-many-dimensions” thing) when
we got into this field. That’s at least 10 years off”.
Second, every respondent (N=145) believed that
BCIs as assistive technology will become available on
the market. Most respondents (42.1% of N=145)
expect a BCI as assistive technology to become
available on the market within the next 5 years,
33.8% between 6 and 10 years and 7.6% in more than
10 years. Almost 17% of the respondents think BCI
as AT is already on the market and mention
predominantly g.tec, which sells the Intendix Home
BCI System, as well as software like OpenVibe and
BCI2000.
Third, most respondents (43.4%, N=145) believe
BCIs as prostheses will become available on the
market between 5 and 10 years. Another large group
(34.5%) believes it will take more than 10 years. One
respondent commented: “It was clear during the
conference that if other muscles/nerves are available,
no company will think to produce [BCI-controlled]
prosthesis for amputated users. If here BCI-controlled
prostheses is intended also for SCI users, I believe
that in more than 10 years it could be available on the
market”. The first probably refers to the keynote
lecture from Dr. Zev Rymer at the 4th International
Fig. 3 These figures show how respondents (in percentages) estimated the time needed for a BCI to reach the market
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BCI conference in Asilomar, which stated that as long
as prostheses or assistive technology can be con-
trolled with remnant muscles or nerve activity, and as
long as the longevity of the neuronal recordings of the
central nervous system remains limited, there will be
no need, let alone a market, for BCI technology.
However, an opposing view argues that BCIs can be
valuable to persons with limited motor function, such
as when these channels are unavailable due to fatigue
[30, 37, 47].
Twenty percent of the respondents believe prostheses
will be on the market within the next 5 years. Two
persons (1.4%) do not think BCI-controlled prosthesis
will ever reach the market and 1 person (0.7%) thinks
such products are already on the market stating that:
“The Parastep-1 system may have been the first,
depending on how strictly you define BCI”.
Fifth, a large group of respondents (39.4%) think
BCIs as therapy tools will become available on the
market within the next 5 years. An equally sized
group believes this will happen between 6 and
10 years. One person believes BCIs will never be on
the market as therapy tools, but unfortunately did not
comment on her choice. Additionally, 9.9% of the
respondents say BCI technologies are already on the
market as therapy tools. Some examples of companies
are EEGInfo and Brainmaster. However, some per-
sons comment that “On the market doesn’t mean it is
proven to work” illustrating the scepticism of many
BCI researchers towards neurofeedback therapy.
Finally, one respondent commented: “Folks who do
DBS are working on plenty of interesting ways to
adaptively program DBS based on user and brain-
signal feedback. That counts as BCI in my book”
illustrating again that the definition of a BCI is critical
in any discussion of ethical or other issues.
To conclude, respondents had different views on
the marketability of different BCI systems. This
creates some challenges for ethical discussions,
because it is difficult to determine which issues are
most urgent without agreement on which BCIs are
most imminent.
Ethical Issues Related to BCIs as Assistive Technology
Informed Consent
Before asking respondents to rate their agreement
with statements about the informed consent pro-
cess, we explained that informed consent is the
process in which participants or legal representa-
tives of participants are fully informed about the
study the participant is entering and legally agree
to participation.
We included six items related to informed consent,
since it is an urgent practical issue in BCI research
[22, 61]. We first review the statements that focus on
the most vulnerable patients who are in the complete
locked-in state (CLIS). CLIS patients cannot commu-
nicate in any way, whereas locked-in patients (LIS)
usually have minimal residual muscle movement with
which they can signal yes/no responses to questions
caregivers, legal representatives or researchers might
ask [27, 29]. The informed consent process with LIS
patients takes effort and time, but can be straightfor-
ward. Haselager and colleagues suggested some
guidelines researchers could follow when engaging
with a legal representative and LIS patient in this
process [22]. However, it is unclear how the BCI
researchers should act when, as has been experienced,
family members of CLIS patients ask BCI laboratories
for an intervention.
Table 3 provides an overview of the answers of the
respondents. Most respondents (75.7%) mostly or
completely disagree that a person who cannot
communicate cannot be included in BCI studies even
when their legal representative agrees with participa-
tion. When we phrased this differently, most respond-
ents (74.1%) mostly or completely agreed that
patients who cannot communicate can be included in
BCI studies when the legal representative asks for a
BCI intervention. However, some respondents com-
mented that inclusion of complete locked-in patients
who cannot communicate in BCI studies depends
on whether or not the BCI would use non-invasive
or invasive recording. Respondents argued that
CLIS patients should not be included in invasive
studies or suggested that patients could set up a
living will that specifies under “which constraints a
BCI experiment may take place”. The urgency of this
last suggestion is illustrated by the fact that most
patients do not have living wills or do not have
precisely formulated living wills even for life-
treatments (e.g. tracheotomy) [36].
Consequently, 67% of the respondents mostly or
completely disagreed that one should still attempt
to provide a BCI to a non-communicative patient
when the legal representative does not agree.
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Twenty-one percent indicated not knowing the
answer, but some commented again that it
depended on the invasiveness of the recording.
Seventeen persons (11.9%) mostly or completely
agreed a BCI intervention should be attempted
even if the legal representative does not agree.
Three people commented on their choice. The first
person asked: “what if the person has clearly
expressed his/her thoughts about “extreme” treat-
ments (before getting into a LIS)?” The second and
third person only agreed to this option when the BCI
procedure was non-invasive. One of the five persons
who completely agreed in our survey commented (in
personal communication with one of the authors)
that it would be unethical not to attempt to help this
people.
Thus, the BCI community seems to have a general
consensus that CLIS (non-communicative) patients
can be included in non-invasive BCI research when
the legal representatives agree. However, the BCI
community seems to generally agree that CLIS
patients should not be included in invasive BCI
research or when the legal representative does not
agree. Although in theory legislation exists about
how and when to include legally incompetent
persons in scientific studies, the opinion of the
researchers does influence the legal representative.
The legal representative, who may be faced with a
non-communicative patient, may not have the
background needed to scrutinize the information
given by the research team. If the research team
presents the study plan too optimistically the legal
representative may not realize this.
Researchers did not agree on videotaping the
process of obtaining an informed consent in a case
with a LIS patient. Fifty-five percent of the
respondents mostly or completely agreed that the
process should be video-taped, but 32% did not
know.
Finally, we focused on the question of which
person(s) should inform LIS patients about BCI
studies, the risks and the benefits. Sixty-three percent
of the respondents mostly or completely agreed that
the BCI expert is appropriate, but 66% of the
respondents also agreed that a medical doctor is
appropriate. Twelve persons commented that these
persons should work together or at least that knowl-
edge from both or more disciplines is necessary. The
presence of a medical doctor in the informed consent
process is even more desired by some respondents
when invasive BCI methods are used. One person
expressed concern that BCI researchers may be
Table 3 Overview of statements regarding the informed
consent process. Columns 2 to 5 show the percentage of
respondents (dis)agreeing (with the extent indicated in the
column) to the different statements The last column (response
count) indicates how many respondents scored the statement
Statement Disagree
completely
Mostly
disagree
I don’t know Mostly agree Agree
completely
Response
count
People who cannot communicate in any way should
*not* be included in BCI studies even if their legal
representative agrees with their participation
33.3 42.4 12.5 9.7 2.1 144
Obtaining an informed consent from a locked-in patient
should be video-taped
4.2 9.0 31.9 34.7 20.1 144
A BCI expert is the suited person to inform the
locked-in patients about the BCI studies, the risks
and the benefits
4.9 18.8 13.2 49.3 13.9 144
A medical expert is the suited person to inform the
locked-in patients about the BCI studies, the risks and
the benefits
2.1 17.6 14.8 59.2 6.3 142
If a patient has no means to communicate but the legal
representative of a patient asks for a BCI intervention
then an attempt should be made to provide him or her
with a BCI
0 8.4 17.5 53.8 20.3 143
If a patient has no means to communicate, and the legal
representative does not agree to a BCI intervention,
you should still attempt to provide a BCI
37.8 29.4 21 8.4 3.5 143
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biased, another that computer scientists are not
necessarily equipped or sufficiently experienced to
have such conversations. Finally, one person may
have expressed the general concern well: “I do not
believe that a single party can, in all situations,
adequately inform the patient about all issues
concerning a BCI study. In such cases, I believe it
would be more appropriate for experts with comple-
mentary areas of expertise .... to inform the patient.
This raises the issue of whether multiple perspectives
are consistent. It is not clear to me how this can be
resolved systematically”.
We could cautiously conclude that the BCI
community acknowledges the role of the BCI
expert and the medical doctor in the process of
obtaining informed consent, but that a broader
debate is needed on this topic. Haselager et al.
(2009) point out that, in relation to team responsi-
bility and patient communication, much can be
learned from interdisciplinary teams such as inten-
sive care units (ICU), teams concerned with
patients who have severe mental disorders [31], or
chronic or progressively ill patients facing end-of-
life care decisions. Thus, we suggest that we could
learn from similar cases in the medical system (e.g.
in relation to surgery with very elderly people). The
BCI community might benefit from a state-of-the-
art overview of medical decision making proce-
dures. We suggest that, at future BCI workshops
and conferences, the organizers could invite experts
on medical decision making to inform the audience
and contribute to the debate. Another practical
recommendation could be to assess perspectives
on BCI, risks and benefit in different disciplines
and establish (and evaluate) an overall consistent
position. Without consistency we might have to
conclude that obtaining informed consent will
always be a custom-tailored process to each
individual, but (some) consistency could facilitate
tentative guidelines avoiding unacceptably large
‘local variations’ (see for further recommendation
the section on “team responsibility”).
Benefits and Risks
A thorough analysis of risks and benefits is essential
for both medical decisions and ethical evaluations.
However, the scientific community has not yet
established a reasonable expectancy of the possible
benefit of a BCI. Moreover, for people who are (on
the verge of being) locked-in, the potential benefit of
a BCI, lacking alternatives, means the difference
between communicating and not communicating at
all [22]. Here, we asked respondents to rate several
statements about risks and benefits of non-invasive
versus invasive BCIs as assistive technology for
locked-in patients (see Table 4).
Most BCI researchers (87.5%) indicated that they
mostly or completely agreed that the current benefits
outweigh the current risks of non-invasive BCI for
locked-in patients. A somewhat smaller majority
(70.7%) indicated that they mostly or completely
disagree that the risks of non-invasive BCI are largely
unknown.
BCI researchers had different views about the risk-
benefit analysis concerning invasive BCIs. Thirty-
three percent of the respondents did not know
whether the current benefits of invasive BCI out-
weighs the current risks. This outcome corresponds
with the result that more than half of the respondents
mostly or completely agreed that the risks of invasive
BCIs are argely unknown. One respondent com-
mented: “Invasive BCIs are certainly useful. Risks
are likely low, but this is still not proven at this
point”. Another respondent has a different opinion:
“I think the risks of invasive BCI are fairly well-
known, actually. Just not sure the current benefits are
enough. As soon as someone comes out with a good
ECoG-based BCI system I would say the benefits
outweigh the risks, and I wouldn’t think twice about
signing up for an implant myself if I was locked-in”.
Another two respondents pointed out that the risk-
benefit analysis should be done on a patient-by-
patient basis and cannot be generalized to all
patients.
Thus, although there seems to be more agreement
on the risk-benefit analysis of non-invasive BCIs
compared to invasive BCIs, respondents do agree that
empirical data is needed and risk-benefits analysis can
only be done individually.
Like in every other medical intervention it is
essential to distinguish between effectiveness of
the intervention and the patient’s benefit. While
physicians and researchers can judge whether a
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BCI is effective, pure effectiveness dose not entail
a normative justification. Normatively relevant is
the benefit for the patient. While effectiveness is
usually a necessary prerequisite, it also depends on
patient’s individual preferences [10, 60]. We recom-
mend monitoring each patient’s benefits through
open, in-depth interviews following BCI use.
Team Responsibility
Previous and current BCI studies that include severely
paralyzed or locked-in patients involve a large team of
researchers from various disciplines. Team members
typically visit patients 1 or 2 times per week at home
to do experiments [23, 25, 26, 38, 39, 64] and
sometimes patients are involved in studies over years
[6, 41, 55, 57, 64]. Inevitably, patients interact with
many researchers, and conversations about BCIs,
risks and benefits might differ from researcher to
researcher. Since researchers may have different
backgrounds or expectations, as well as different
views about key issues, the responsibility for the
effects of BCIs can become unclear due to team work
[22]. Here, we asked respondents to rate several
statements about team responsibility (see Table 5).
A majority of the respondents (73%) mostly or
completely agree that all BCI teams should have 1
common code with rules and regulations for team
responsibility issues. Respondents also differed on
whether patients can or cannot hear different opinions
from team members. While 41% of the respondents
agree that it is okay that a patient hears the difference
of opinion of various team members considering the
risks and the benefits of a BCI, 60% of the
respondents agree (when formulated differently) that
BCI teams should stick to one risk/benefit analysis.
One respondent wrote: “It’s very important to have
one clear message. The last thing we want is the
patient to become confused”, while another wrote:
“The ability for users and/or patients to obtain a
second opinion is extremely important. This is widely
accepted in other medical professions as well”.
To conclude, BCI researchers seem to disagree
about whether and how BCI teams should operate
and give information as a unit. BCI teams could
learn from other interdisciplinary groups working
in similarly demanding situations such as intensive
care units [31]. Haselager and colleagues recom-
mend several strategies to improve team functioning,
many of which are reasonably obvious (e.g. regular
team meetings, ensuring good lines of communica-
tion), but two recommendations are worth mention-
ing in relation to acquiring informed consent [22].
First, ensure that appropriate members of the team
are asked whether they should be present at a
decision making meetings with patient and family.
Second, have a ‘preconference’ of team members to
develop team consensus and facilitate discussion of
issues or conflicts that may occur within a team
[56].
Consequences of BCI on Patients’ and Familes’ Lives
Most BCI researchers who aim to develop Brain-
Computer Interfaces assume that AT will increase
quality of life for persons with disabilities and their
families. Increased quality of life, or assurance that
communication will remain intact, could very well
Table 4 Overview of statements regarding the risks and
benefits. Columns 2 to 5 show the percentage of respondents
(dis)agreeing (with the extent indicated in the column) to the
different statements The last column (response count) indicates
how many respondents scored the statement
Statement Disagree
completely
Mostly
disagree
I don’t
know
Mostly
agree
Agree
completely
Response
count
The current benefits outweigh the current risks of
non-invasive BCI for locked-in patients
1.4 3.5 7.7 41.3 46.2 143
The risks of non-invasive BCIs are still largely unknown 22.4 48.3 11.2 16.1 2.1 143
The current benefits outweigh the currently risks of
invasive BCI for locked-in patients
11.3 29.6 33.1 23.2 2.8 142
The risks of invasive BCIs are still largely unknown 0.7 24.8 17.7 46.8 9.9 141
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change end-of-life decisions among persons with neuro-
degenerative diseases. One article proposed that AT,
especially AT that requires a difficult and time-
consuming set-up such as current BCI technology, could
add to the burden of the family or caregivers and not aid
them [48].
Sixty-four percent of the respondents thought that
BCI as AT will be a reason for a patient to change
his or her end-of-life decisions, but almost 30% did
not know whether this was true (See Table 6).
Additional concern was expressed by one respon-
dent: “Ultimately, I think that BCI technology will
change end-of-life plans for some people. However, it
is very important that users do not change their end-
of-life plans based on false hopes of obtaining
technology that does not yet exist or is not yet
widely available”.
Forty-seven percent of the respondents mostly or
completely disagreed that BCI will add an extra
burden to the family of the patient. Those who did
believe that BCI could, to some extent, add extra
burden to the family said for example: “…while a
potentially extended lifetime might add to burden,
family members’ perception might be of decreased
burden or intangible gain. This will vary on a case-
by-case basis and will be largely subjective for both
patient and family member”. More than 80% of the
respondents did feel that BCI could also aid families.
The common conclusion might be that BCIs may
bring extra burden but also extra aid. One respondent
said: “it definitely adds a burden, but it also lightens a
load”.
However, ultimately these issues demand empir-
ical investigation. As one respondent stated: “These
are empirical matters, which can only be evaluated
by interrogating the relevant individuals and track-
ing such things as their continued financial solvency
or the quality of filial relations over time”. Addi-
tionally, again the BCI community might benefit
from an investigation of how the medical practice or
companies study the effects of new treatments and
therapies.
Table 6 Columns 2 to 5 show the percentage of respondents (dis)agreeing (with the extent indicated in the column) to the different
statements The last column (response count) indicates how many respondents scored the statement
Statement Disagree
completely
Mostly
disagree
I don’t
know
Mostly
agree
Agree
completely
Response
count
A BCI as assistive technology will be a reason for a
patient to change his or her end-of-life decisions
1.4 4.9 29.4 53.8 10.5 143
BCI as assistive technology will add an extra burden
to the family of the patient
9.2 38.0 33.8 19.0 0.0 142
BCI as assistive technology will aid the family of the patient 0.0 1.4 16.8 72.0 9.8 143
Table 5 Overview of statements regarding team responsibility.
Columns 2 to 5 show the percentage of respondents (dis)
agreeing (with the extent indicated in the column) to the
different statements The last column (response count) indicates
how many respondents scored the statement
Statement Disagree
completely
Mostly
disagree
I don’t
know
Mostly
agree
Agree
completely
Response
count
All BCI teams should have 1 common code with rules
& regulations for team responsibility issues
0.7 14.8 12 45.1 27.5 142
It is okay when a patient hears about the difference op
opinion of various team members considering the
risks and the benefits of a BCI
12.7 31 15.5 29.6 11.3 142
BCI teams should stick to one risk/benefit analysis
and tell this to the patient
4.2 14.1 21.8 43.0 16.9 142
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Liability and Personal Identity
The use of BCI may affect psychological aspects of a
person, including his or her self-perception, types of
behavior characteristic of a person, the capacity to
remember, understand and decide upon information
etc., possibly leading to questions about the psycho-
logical continuity or even personal identity of the
person [2, 53, 54, 63]. Since these capacities are
relevant to the process of informed consent (e.g.
affecting someone’s evaluation of a decision to
continue or stop the use of a BCI) this is not ‘just’
an ethical issue but may also have legal implications
(see [24] for a discussion of this topic in relation to
Deep Brain Stimulation).
Also, BCI use could lead to accidents. For
example, who is liable if a BCI mistakenly interprets
a wheelchair or prosthesis command and causes a user
to hit someone or damage something or cross a street
against a red light [8, 61, 63]?
Sixty-five percent of the respondents mostly or
completely agree that BCI users are responsible for
the actions they execute and the messages they
transmit with this device (See Table 7), although
many respondents (21.5%) don’t know and com-
mented that it would depend on many factors such as
1) the accuracy with which the BCI can decode the
user’s intentions, 2) the knowledge of the user
about the unreliability of the system, 3) state of
functionality at the time of an accident or ‘adverse’
event, 4) the competence of the user, and 5) the
psychological health or state of the user at the time
of the accident or ‘adverse’ event. Respondents are
also unsure (37.1%) whether BCIs as assistive
technology would lead to behaviors uncharacteristic
of the user’s identity and comment that even if it
would change personal identity, this might not be
necessarily negative. For example, neurofeedback
has been hypothesized to reduce the symptoms of
autism and anti-personality disorder [49, 59] and
may change a person’s identity in fundamental but
desirable ways.
Also, few comments demonstrate that some BCI
researchers are worried that ethical guidelines will
superimpose a particular moral perspective on
patients: “perhaps a BCI user’s “identity” would
change once they had used the system for a while.
But it would be beyond arrogant to tell them ‘I think
this might change your identity, so I am not allowing
you to use this technology’”. In addition to this very
basic ethical question, the possibility of BCI induced
changes in cognitive capacities, psychological conti-
nuity or personal identity needs to be considered to
assess issues concerning informed consent and/or
personal liability.
Finally, respondents again commented that these
issues should be investigated empirically, with the
explicit consideration of the many factors influ-
encing BCI use and likely outcomes. We agree and
thus recommend that future clinical trials involving
BCI systems investigate personality changes over
time.
Interaction with the Media
BCI research, whether non-invasive or invasive,
receives a great deal of media attention (e.g. [1, 11,
21, 46, 65]). The media in turn is read by policy
makers and stakeholders and may influence their
opinions and expectancies, which, in turn, might
Table 7 Columns 2 to 5 show the percentage of respondents (dis)agreeing (with the extent indicated in the column) to the different
statements. The last column (response count) indicates how many respondents scored the statement
Statement Disagree
completely
Mostly
disagree
I don’t
know
Mostly
agree
Agree
completely
Response
count
BCI users are responsible for the actions they execute
and the messages they transmit with the device
1.4 11.8 21.5 57.6 7.6 144
BCIs as assistive technology could lead to behaviors
uncharacteristic of the user’s personal identity
5.6 27.3 37.1 28.0 2.1 143
BCIs as assistive technology will not change a person’s identity 0.7 11.9 33.6 42.0 11.9 143
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affect the availability of funding for BCI research.
Here we asked BCI researchers how BCI researchers
should disseminate results to the media.
Over 80% of the respondents agreed that BCI
scientists have a responsibility to check whether
journalists accurately separate factual from fictitious
statements (See Table 8). However, as one respondent
commented: “We can try our best to get correct info
out there and ask to review anything a reporter writes
before it goes to press, but sometimes it is simply out
of our control”. A similar majority agreed that BCI
scientists should actively speak out against inaccurate
media statements and should moderate enthusiasm
when speaking to the media. Respondents did not
agree on whether BCI scientists should restrict
themselves to discussing only current or near-future
applications of BCI. One respondent commented:
“Scientists have the duty to tell facts. But that doesn’t
mean they cannot be enthusiastic about their field and
have a vision”.
Thus, there seems to be a consensus among BCI
scientists to moderate enthusiasm when speaking to
the media and to actively check and correct
representations in the media whenever needed and/
or possible. However, BCI scientists disagree on
whether they should restrict themselves in speaking
about what is currently possible, or may speak
about their expectations for future BCIs. Schermer
points out that future brain-machine interaction
technologies may entail political and ideological
functions, since they help to secure research funds
and to create a certain image of these develop-
ments, thus steering the public opinion [54]. We do
recommend that scientists realistically portray their
findings to the media and to academic journals. BCI
developers should also thoroughly and accurately
report methods in scientific papers, such as stating
whether they include time between selections of
targets in the calculation of the communication rate
[4, 35, 62]. Another good practice for industrial BCI
developers would be to realistically describe how
much of the product relies on brain signal and how
much on muscle signals.
Urgent Matters in the BCI Community
Finally, we asked respondents to indicate when certain
BCI issues need to be settled. Figure 4 gives an
overview. We will discuss these issues in order from
most urgent to least urgent issues that need to be
settled within the next 2 years.
First, 79% of the respondents (N=143) indicated a
standard BCI definition should be clarified within
5 years. However, those who disagreed often had
strong opinions, with one respondent commenting: “I
don’t see a real reason to have a stand alone
definition.... for BCI. Science these days is very
interdisciplinary and trying to define borders is
somewhat artificial (and not necessarily beneficial)”.
Another respondent commented: “not to be incendiary,
Table 8 Columns 2 to 5 show the percentage of respondents (dis)agreeing (with the extent indicated in the column) to the different
statements The last column (response count) indicates how many respondents scored the statement
Statement Disagree
completely
Mostly
disagree
I don’t
know
Mostly
agree
Agree
completely
Response
count
It is the responsibility of scientists to check whether
their separation from the facts and fiction is
adequately represented by journalists
2.1 9.1 7.7 51.0 30.1 143
BCI scientists should moderate their enthusiasm
when speaking to the media
1.4 12.6 9.8 37.8 38.5 143
Each BCI scientist should restrict him/herself to
discussing current and near-future applications of
BCI instead of speculating about long-term
applications
3.5 31.9 9.7 36.8 18.1 144
BCI scientists should actively speak out against
inaccurate statements in the media, regardless
of the source
0.0 4.2 9.0 47.2 39.6 144
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but who cares, really?” Another example is: “it seems
kind of ridiculous to argue over what is and isn’t a BCI.
It is more important to argue about what methods,
technology, therapies, interventions etc. are useful and
which ones aren’t. A product should be measured on
how much it can help a person rather than whether or
not it meets some technical definition of a BCI”.
Finally, one person said: “I am categorically against
categorization. We can certainly waste our breath
classifying things as BCI or not BCI, but please let’s
not try to build towers of logic that build upon that
distinction as one of its foundations. That’s what
philosophers do—philosophy is a fine leisure pastime,
but it hinders us more than it helps us in solving
concrete practical problems”.
Although we authors do not all agree on whether
a standard definition is necessary for most stake-
holders, we do all agree, as indicated before, that
having great variance in the definition of a BCI can
be detrimental to the clarity of the ethical debate.
Policy makers and the general public will need a
clarification of how differences in interpretation
bear upon the ethical discussion. Second, 86% of
the respondent would like to see ethical guidelines
specific to BCI research and BCI use within 5 years.
More than half of the respondents (57%) would like
to see these guidelines within only 2 years. One
respondent cautiously added: “Ethical guidelines for
BCI research and use might be useful, but could be
detrimental if the guidelines are not comprehensive
and thorough”. Also Nordmann and Rip pointed out
that the field of neural engineering, which is still in
its infancy, should avoid the trap of “speculative
ethics” [45]. The neuroethical debate should be
grounded on thorough knowledge about the technol-
ogies under discussion.
Yet, some people do not consider ethical guidelines
necessary, since they already exist: “At least the US
has well-vetted certification processes for conducting
human subjects research. This is a non-issue.... The
global rules applied to all human research (including
research with locked in patients). Nothing special is
needed for BCIs”.
Third, we asked respondents if and when a
certification process should be set up to determine if
a BCI scientist is qualified to work with patients.
Sixty-five percent of the respondents think such a
certification process should be set up within the next
5 years. This result may reflect the respondents’ doubt
about which kind of person(s) would be appropriate
Fig. 4 An overview of
when respondents think
certain BCI issues should be
settled. From top to bottom
bar: ‘a certification process
to determine that the
product is adequate for a
BCI’, ‘a regular journal
devoted solely to BCI
research’, ‘a certification
process to determine that a
BCI scientist is qualified to
work with patients’, ‘ethical
guidelines specific to BCI
research and BCI use’ and
‘a standard definition of
what a BCI is’
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to communicate with the patient and who should be
responsible for that (see section “Informed Consent”).
Fourth, we asked respondents if and when a
certification process should be set up to determine if
a product should be dubbed a BCI. More than half of
the respondents wanted such a certification process
within the next 5 years, but several persons also
indicated they either did not know what we meant
with a certification process. Additionally persons feel
that “BCI researchers don’t need their own special
certification. The field is too diverse for that to work
anyway’.
Fifth, 29.7% of the respondents would like to have
a regular journal devoted solely to BCI research
within the next 2 years and 34.1% within the next
5 years. However, another large group (26.1%) do not
consider a specific journal as an urgent matter. One
respondent commented: “I think the journal is
unnecessary — if it’s good work, it will get into
bigger, higher volume journals like Nature or Science
or Neuroscience, which helps the field as a whole”.
Thus, respondents selected terminological and
ethical issues as the most urgent matters from the list
we presented to them. Certification procedures for
BCI technology and a journal were regarded as less
urgent.
Discussion
Some Thoughts on the Survey
Here we will discuss how our survey was received by
the respondents based on the statistics of their
responses and some follow up questions asked at the
end of the survey.
First, half of the attendees of the conferences
took the time to complete the survey. Several
respondents commented at the conference site that
they appreciated this study. Some also said the
survey itself triggered their awareness about ethical
issues in their daily work. Moreover, 103 respond-
ents gave their email address in an optional field of
the survey so we could forward any dissemination
on these results and 42 skipped this question. Thus,
a clear interest among BCI researchers in the issues
raised is visible.
Finally, we asked respondents to add any questions
they felt we should have included in the survey. These
comments help identify the completeness of our
survey, and could help improve future efforts.
Twenty-eight persons decided to add more questions.
117 skipped this question. We interpret this as a sign
we covered relevant issues well. We will discuss some
questions respondents suggested us to add. First, one
respondent said: “I can’t help but notice that no
questions were raised about the moral status of using
nonhuman animals in testing various BCIs”. Indeed,
the current survey only assessed opinions about
ethical issues related to BCIs which are used as AT
for humans with disabilities. An ethical debate on
all BCI research would also include debates on
BCIs which are used to control prostheses (which
typically involves research with invasive recording
with animals). In addition, as one respondent
commented, also no attention was given to
“ethical issues for non-patients”. BCI-controlled
games are already commercially available and BCI
researchers are increasingly applying BCI technol-
ogies in gaming or human-computer interaction
(HCI) [43, 44, 72]. Ethical, societal and legal issues
related to BCI for gaming or HCI may differ greatly
from the issues related to BCIs for medical purposes.
For example, if BCIs were used to track fatigue
levels of air traffic controllers, then issues like
workers’ rights and privacy of mind may be more
imminent topics.
Finally, one respondent (critically?) noted: “When
does a questionnaire need to be given to the scientific
community?” Two considerations follow from this.
First, should such a questionnaire be given to the
scientific community at all? And second, how often
should you survey opinions? After all, BCI is a
relatively new field, and the ethical debate about its
applications and implications is still in its infancy.
Therefore BCI researchers may not yet have fully
developed well-informed opinions about ethical
issues. Likewise, ethicists may not yet have thorough
knowledge about neurotechnologies and have there-
fore difficulties to understand what is and what is not
possible. Also, in such a rapidly developing field
opinions might well change which leads to the
question whether surveys should be repeated and if
yes, after how much time.
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Despite these reservations, we think this survey
was timely, if not a little early, to initiate bridging the
gap between the different perspectives existing between
neuroengineers (here the BCI community), and also
between them and the neuroethicists. Moreover, reflect-
ing on the questions, and the answers they raised, may
assist in structuring the growing public debate on BCI.
As a caveat, the sample of respondents do not
adequately represent all of the researchers working on
BCI technologies. For example, no African, South-
American or Australian BCI groups were present
at the Asilomar conference, although these groups
are also much less prominent in the BCI literature.
Also, only twelve respondents in our sample began
BCI research before 2000, which implies that other
well-established and experienced BCI researchers
did not complete the survey. Although, as men-
tioned before, the field of BCI consists of many
young researchers, it remains desirable to repeat a
questionnaire of this kind in the near future with
different stakeholders.
In addition to our suggestions for conduction new
surveys with various improvements, we recommend
other future directions. Additional collaborative
efforts such as workshops, special sessions, web-based
meetings and joint publications (of neuroengineers
and ethicists) could introduce and encourage a
wider view of different issues. These efforts could
work toward ethical guidelines or recommendations
with broader distribution and more credibility.
Legal issues such as liability, privacy and personal
identity should also be explored through appropriate
eclectic collaboration.
Final Remarks
In the introduction, we listed as many as 17 ethical
issues that have been identified in the literature. It
is not surprising that neurotechnologies like Brain-
Computer Interfacing raise so many questions.
BCIs, like technologies such as DBS or vagal
nerve stimulation, confront humanity with issues of
existential nature. Who are we? Are we only our
brain, and can our brain and personality really be
so easily modulated with technologies? Do we
want technologies to be inside of our bodies and
brains?
On the 10th of November 2010 a Science and
Technology Options Assessment (STOA) conference
entitled “making perfect life — bioengineering in the
21st century” was held in the European Parliament.
After listening to all the issues that arise with the
current merge between information technology, nano-
technology, neuroscience and biology, member of
parliament Vitorrio Prodi remarked: “We are living in
an era of change where we really need to think ahead
in order to protect human dignity.” Indeed, while
neuroengineering leaps ahead, neuroethical consider-
ations should not lag behind. We strongly support a
thorough and continuing ethical debate on neuro-
technologies that involves contributors from neuro-
engineering, neuroscience, neuroethics, philosophy,
politics, journalism and the general public. Resources
should be made available for this ethical debate. Van
Keulen and Schuijff comment: “it is remarkable that,
unlike with emerging technologies like synthetic
biology and nanotechnology, the EU is not yet
funding any large ethical, legal and/or sociological
project in neurosciences, or in neural engineering for
that matter” (p. 123;[63]). We recognize that there are
many issues that need further exploration even after
this survey, but hope our paper encourages such
further discussion.
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